Epitope mapping of ADAMTS 13 autoantibodies in acquired thrombotic thrombocytopenic purpura

被引:170
作者
Klaus, C
Plaimauer, B
Studt, JD
Domer, F
Lämmle, B
Mannucci, PM
Scheiflinger, F [1 ]
机构
[1] Baxter BioSci, Ctr Biomed Res, Uferstr 15, A-2304 Orth, Austria
[2] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland
[3] IRCCS, Maggiore Hosp, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[4] Univ Milan, Milan, Italy
关键词
D O I
10.1182/blood-2003-12-4165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe deficiency of the von Willebrand factor (VWF)-cleaving protease ADAMTS13 can lead to thrombotic thrombocytopenic purpura (TTP), a disease associated with the widespread formation of platelet-rich thrombi in many organs. Autoantibodies that inactivate ADAMTS13 are the most frequent cause of acquired TTP. Little is known about epitope specificity and reactivity of anti-ADAMTS13 antibodies. In this study, a series of ADAMTS13 domains were expressed in Escherichia coli, and the reactivity of purified recombinant fragments with anti-ADAMTS13 auto-antibodies from 25 patients with severe ADAMTS13 deficiency was evaluated in vitro. All TTP plasmas contained antibodies directed against the cysteine-rich spacer (cys-rich/spacer) domain of ADAMTS13. In the plasma of 3 patients, antibodies were detected that reacted exclusively with the cys-rich/spacer domain, underscoring the importance of this region for functional activity of ADAMTS13. In 64% of the plasmas, antibodies reacted with the 2 CUB domains, and in 56% they reacted with the isolated first thrombospondin type 1 (TSP-1) repeat and with the compound fragment consisting of the catalytic, the disintegrin-like, and the TSP1-1 domain. Less frequently, in 28% of the plasmas, antibodies reacted with the TSP1 repeats 2 to 8. Unexpectedly, antibodies reacted with the propeptide region in 20% of the plasmas. In conclusion, this study shows that even though anti-ADAMTS13 autoantibodles react with multiple domains of the protease, the cys-rich/spacer domain is consistently involved in antibody reactivity. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:4514 / 4519
页数:6
相关论文
共 48 条
[41]   ANTI-CD36 ANTIBODIES IN THROMBOTIC THROMBOCYTOPENIC PURPURA [J].
TANDON, NN ;
ROCK, G ;
JAMIESON, GA .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 88 (04) :816-825
[42]   Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura [J].
Tsai, HM ;
Lian, ECY .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1585-1594
[43]   Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion [J].
Tsai, HM .
BLOOD, 1996, 87 (10) :4235-4244
[44]   ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome:: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients [J].
Vesely, SK ;
George, JN ;
Lämmle, B ;
Studt, JD ;
Alberio, L ;
El-Harake, MA ;
Raskob, GE .
BLOOD, 2003, 102 (01) :60-68
[45]   Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases [J].
Veyradier, A ;
Obert, B ;
Houllier, A ;
Meyer, D ;
Girma, JP .
BLOOD, 2001, 98 (06) :1765-1772
[46]  
VEYRADIER A, 2003, J THROMB HAEMOST S1, V1
[47]   Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura [J].
Zheng, XL ;
Chung, D ;
Takayama, TK ;
Majerus, EM ;
Sadler, JE ;
Fujikawa, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41059-41063
[48]   Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13 [J].
Zheng, XL ;
Nishio, K ;
Majerus, EM ;
Sadler, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) :30136-30141